Hostname: page-component-848d4c4894-75dct Total loading time: 0 Render date: 2024-05-28T12:13:09.425Z Has data issue: false hasContentIssue false

Health Economic Reviews: Are They Compiled Systematically?

Published online by Cambridge University Press:  10 March 2009

Kathryn Rigby
Flinders University
Christopher Silagy
Flinders University
Alan Crockett
Flinders Medical Centre


Attempts to perform economic reviews of randomized controlled trials frequently lack a systematic approach. This conclusion is consistent with the findings of previous analyses of review articles in other fields, which have highlighted the failure to apply the same degree of rigor to this type of research synthesis that the scientific community has come to expect from primary research articles.

General Essays
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)



1.Adams, M. E., McCall, N. T., Gray, D. T., et al. Economic analysis in randomised controlled trials. Medical Care, 1992, 30, 231–42.CrossRefGoogle Scholar
2.Blades, C. A., Culyer, A. J., & Walker, A.Health service efficiency: Appraising the appraisers: A critical review of economic appraisal in practice. Social Science & Medicine, 1987, 25, 461–72.CrossRefGoogle ScholarPubMed
3.Brown, M. L. & Fintor, L. M.Cost-effectiveness of breast cancer screening: Preliminary results of a systematic review of the literature. Breast Cancer Research and Treatment, 1993, 25, 113–18.CrossRefGoogle ScholarPubMed
4.Chalmers, I., Enkin, M., & Keirse, M. J.Preparing and updating systematic reviews of randomised controlled trials in health care. Milbank Quarterly, 1993, 71, 411–37.CrossRefGoogle Scholar
5.Cohen, D. R., & Fowler, G. H.Economic implications of smoking cessation therapies: A review of economic appraisals. PharmoEconomics 1, 1993, 4, 331–44.CrossRefGoogle ScholarPubMed
6.Drummond, M. F.Australian guidelines for cost-effectiveness studies of Pharmaceuticals. The thin end of the boomerang? PharmacoEconomics 1, 1992, 1(suppl.1), 6169.CrossRefGoogle ScholarPubMed
7.Drummond, M. F.Evaluation of health technology: Economic issues for health policy and policy issues for economic appraisal. Social Science & Medicine, 1994, 38, 15931600.CrossRefGoogle ScholarPubMed
8.Drummond, M. F.Principles of economic evaluation in health care. Oxford: Oxford University Press, 1980.Google Scholar
9.Drummond, M. F., Bloom, B. S., Carrin, G., et al. Issues in the cross-national assessment of health technology. International Journal of Technology Assessment in Health Care, 1992, 8, 671–82.CrossRefGoogle ScholarPubMed
10.Drummond, M. F., Brandt, A., Luce, B., & Rovira, J.Standardizing methodologies for economic evaluation in health care: Practice, problems and potential. International Journal of Technology Assessment in Health Care, 1993, 9, 2636.CrossRefGoogle ScholarPubMed
11.Drummond, M. F., & Davies, L.Economic analysis alongside clinical trials: Revisiting the methodological issues. International Journal of Technology Assessment in Health Care, 1991, 7, 561–73.CrossRefGoogle ScholarPubMed
12.Drummond, M. F. & Stoddart, G. L.Economic analysis and clinical trials. Controlled Clinical Trials, 1984, 5, 115–28.CrossRefGoogle ScholarPubMed
13.Drummond, M. F. & Stoddart, G. L.The economic evaluations of health care technologies. Oxford: Oxford University Press, 1987.Google Scholar
14.Eddy, D. M.Selecting technologies for assessment. International Journal of Technology Assessment in Health Care, 1989, 5, 485501.CrossRefGoogle ScholarPubMed
15.Elixhauser, A.Costs of breast cancer and the cost-effectiveness of breast screening. International Journal of Technology Assessment in Health Care, 1881, 7, 604–15.CrossRefGoogle Scholar
16.Elixhauser, A., Luce, B. R., Taylor, W. R., & Reblando, J.Health care CBA/CEA: An update on the growth and composition of the literature. Medical Care, 1993, 31 (suppl.) S111.CrossRefGoogle ScholarPubMed
17.Evans, R. G., & Robinson, G. C.Surgical day care: Measures of economic payoff. Canadian Medical Association Journal, 1980, 123, 373–80.Google ScholarPubMed
18.Finkler, S. A.The distinction between costs and charges. Annals of Internal Medicine, 1982, 96, 102–09.CrossRefGoogle Scholar
19.Freemantle, N., & Maynard, A.Something rotten in the state of clinical and economic evaluations? (editorial) Health Economics, 1994, 31, 6367.CrossRefGoogle Scholar
20.Gerard, K.Cost-utility analysis: A policy makers guide to the state of the art. Health Policy, 1992, 21, 249–79.CrossRefGoogle Scholar
21.Gerard, K., & Mooney, G.QALY league tables: Handle with care. Health Economics, 1993, 2, 5964.CrossRefGoogle ScholarPubMed
22.Goldberg, D.Cost-effectiveness studies in the treatment of schizophrenia: A review. Social Psychiatric Epidemiology, 1991, 26, 139–42.CrossRefGoogle ScholarPubMed
23.Guyatt, G., Drummond, M., Feeny, D., et al. Guidelines for the clinical and economic evaluation of health care technologies. Social Science & Medicine, 1986, 22, 393408.CrossRefGoogle ScholarPubMed
24.Henshall, C.Economic appraisal in the British national health service. Social Science & Medicine, 1994, 38, 1675–78.CrossRefGoogle ScholarPubMed
25.Jefferson, T., & Demichael, V.Is vaccination against hepatitis B efficient? A review of world literature. Health Economics, 1994, 3, 2537.CrossRefGoogle ScholarPubMed
26.Johannesson, M., & Jonsson, B.A review of cost-effectiveness analyses of hypertension treatment. PharmoEconomics I, 1992, 1, 250–64.CrossRefGoogle ScholarPubMed
27.Luce, B. R., & Elixhauser, A.Estimating costs in the economic evaluation of medical technologies. International Journal of Technology Assessment in Health Care, 1990, 6, 5775.CrossRefGoogle ScholarPubMed
28.McEwan, R. T., & Forster, D. P.A review of the costs and effectiveness of assessing the elderly in general practice. Family Practice, 1993, 10, 5562.CrossRefGoogle ScholarPubMed
29.Mulrow, C. D.Systematic reviews: Rationale for systematic reviews. British Medical Journal, 1994, 309, 597–99.CrossRefGoogle ScholarPubMed
30.Mulrow, C. D.The medical review article: State of the science. Annals of Internal Medicine, 1987, 106, 485–88.CrossRefGoogle ScholarPubMed
31.Patton, D. D.Cost-effectiveness in nuclear medicine. Seminars in Nuclear Medicine, 1993, 23, 930.CrossRefGoogle ScholarPubMed
32.Pettiti, D. B.Sounding board: Competing technologies: Implications for costs and complexity of medical care. New England Journal of Medicine, 1986, 315, 1480–83.Google Scholar
33.Rutten-Van Molken, M. P. M. H., Van Doorslaer, E. K. A., & Rutten, F. F. H.Economic appraisal of asthma and COPD care: A literature review 1980–1991. Social Science & Medicine, 1992, 35, 161–75.Google Scholar
34.Schoenbaum, S. C.Cost/effectiveness considerations in clinical trials. Triangle, 1980, 19, 103–05.Google ScholarPubMed
35.Silagy, C.Developing a register of randomised controlled trials in primary care. British Medical Journal, 1993, 306, 897900.CrossRefGoogle ScholarPubMed
36.Simes, J. D., & Glasziou, P. P.Meta-analysis and quality of evidence in the economic evaluation of drug trials. PharmacoEconomics I, 1992, 1, 282–92.CrossRefGoogle ScholarPubMed
37.Udvarhelyi, S., Colditz, G. A., Rai, A., & Epstein, A. M.Cost-effectiveness and costbenefit analyses in the medical literature: Are the methods being used correctly? Annals of Internal Medicine, 1992, 116, 238–44.CrossRefGoogle ScholarPubMed
38.Warner, K. E., & Hutton, R. C.Cost-benefit and cost-effectiveness analysis in health care: Growth and composition of the literature. Medical Care, 1980, 18, 1069–84.CrossRefGoogle ScholarPubMed